HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy
Peroxisome proliferator-activated receptors (PPARs) regulate cardiac glucose and lipid homeostasis. Histone deacetylase (HDAC) inhibitor has anti-inflammatory effects which may play a key role in modulating PPARs and fatty acid metabolism. The aim of this study was to investigate whether HDAC inhibi...
Saved in:
Main Authors: | Ting-I Lee, Yu-Hsun Kao, Wen-Chin Tsai, Cheng-Chih Chung, Yao-Chang Chen, Yi-Jen Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2016/5938740 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism
by: Erin McLean, et al.
Published: (2025-01-01) -
Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
by: Yongpan Li, et al.
Published: (2022-01-01) -
PPARs and Metabolic Syndrome
by: Lihong Chen, et al.
Published: (2014-01-01) -
The Correlation of PPARα Activity and Cardiomyocyte Metabolism and Structure in Idiopathic Dilated Cardiomyopathy during Heart Failure Progression
by: E. Czarnowska, et al.
Published: (2016-01-01) -
A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance
by: Wei-Wen Chen, et al.
Published: (2024-01-01)